Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
SEOULEAGUER Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩653.00 |
52 Week High | ₩852.00 |
52 Week Low | ₩531.00 |
Beta | 1.29 |
11 Month Change | -7.90% |
3 Month Change | -7.64% |
1 Year Change | -2.39% |
33 Year Change | -55.73% |
5 Year Change | -59.06% |
Change since IPO | -97.67% |
Recent News & Updates
Is SEOULEAGUER (KOSDAQ:043710) Using Debt In A Risky Way?
Sep 06SEOULEAGUER Co., Ltd.'s (KOSDAQ:043710) Shares Not Telling The Full Story
Jun 20Shareholder Returns
A043710 | KR Healthcare | KR Market | |
---|---|---|---|
7D | -0.6% | 5.8% | -0.5% |
1Y | -2.4% | 9.9% | 7.3% |
Return vs Industry: A043710 underperformed the KR Healthcare industry which returned 9.9% over the past year.
Return vs Market: A043710 underperformed the KR Market which returned 7.3% over the past year.
Price Volatility
A043710 volatility | |
---|---|
A043710 Average Weekly Movement | 8.2% |
Healthcare Industry Average Movement | 7.2% |
Market Average Movement | 6.8% |
10% most volatile stocks in KR Market | 12.2% |
10% least volatile stocks in KR Market | 3.6% |
Stable Share Price: A043710 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A043710's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1991 | 12 | Paek-Chol Kim | www.seouleaguer.net |
SEOULEAGUER Co., Ltd. engages in the healthcare and MSO business in South Korea. The company is involved in pharmaceuticals wholesale and retail; and cosmetics manufacturing and retail businesses. It also provides medical facility operation, and management support project; and offers mobile accessories.
SEOULEAGUER Co., Ltd. Fundamentals Summary
A043710 fundamental statistics | |
---|---|
Market cap | ₩32.78b |
Earnings (TTM) | -₩12.33b |
Revenue (TTM) | ₩19.07b |
1.7x
P/S Ratio-2.7x
P/E RatioIs A043710 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A043710 income statement (TTM) | |
---|---|
Revenue | ₩19.07b |
Cost of Revenue | ₩17.45b |
Gross Profit | ₩1.62b |
Other Expenses | ₩13.94b |
Earnings | -₩12.33b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -245.57 |
Gross Margin | 8.47% |
Net Profit Margin | -64.65% |
Debt/Equity Ratio | 15.6% |
How did A043710 perform over the long term?
See historical performance and comparison